Cardinal Health (CAH) Cash & Equivalents (2009 - 2026)

Cardinal Health (CAH) has 18 years of Cash & Equivalents data on file, last reported at $3.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 18.37% year-over-year to $3.9 billion; the trailing twelve-month figure through Mar 2026 stood at $3.9 billion (up 18.37% YoY), and the FY2025 full-year result was $3.9 billion, down 24.53% from the prior year.
• Cash & Equivalents advanced to $3.9 billion in Q1 2026, from $2.8 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $5.1 billion in Q2 2024 to a low of $2.4 billion in Q1 2022.
• A 5-year average of $3.8 billion and a median of $3.9 billion in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 32.67% in 2022 and soared 69.35% in 2023, its largest moves.
• Tracing CAH's Cash & Equivalents over 5 years: stood at $3.7 billion in 2022, then advanced by 25.64% to $4.6 billion in 2023, then dropped by 17.01% to $3.8 billion in 2024, then fell by 27.11% to $2.8 billion in 2025, then surged by 41.77% to $3.9 billion in 2026.
• Business Quant data shows CAH's Cash & Equivalents at $3.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $4.6 billion in Q3 2025.